tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium

C69H116N42O30P6S5Si — CID 157079938

About tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium

tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium (PubChem CID 157079938) has the molecular formula C69H116N42O30P6S5Si and a molecular weight of 2388.22 g/mol. Its IUPAC name is tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium.

Molecular Properties

• Compound Name: tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium
• PubChem CID: 157079938
• Molecular Formula: C69H116N42O30P6S5Si
• Molecular Weight: 2388.22 g/mol
• Exact Mass: 2386.56
• IUPAC Name: tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium
• SMILES: C[C@@H]1[C@@H]2NP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]3NP(=O)([S-])OC[C@H]2O[C@H]1n1cnc2c(=O)[nH]c(N)nc21.C[NH3+].C[NH3+].Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP([O-])(=S)N[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)([O-])N[C@H]3[C@H]2O)c(=O)[nH]1.Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP([O-])(=S)N[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP([O-])(=S)N[C@H]3[C@H]2O)c(=O)[nH]1.[NH4+].[NH4+].[NH4+].[NH4+]
• InChI: InChI=1S/C27H42N12O9P2S2Si.C20H26N12O11P2S.C20H26N12O10P2S2.2CH5N.4H3N/c1-11-14-12(46-23(11)38-9-30-16-19(38)32-25(28)34-21(16)40)7-44-50(43,52)37-15-13(8-45-49(42,51)36-14)47-24(18(15)48-53(5,6)27(2,3)4)39-10-31-17-20(39)33-26(29)35-22(17)41;21-19-25-13-9(15(35)27-19)23-3-31(13)17-11(33)7-6(43-17)2-41-45(39,46)30-8-5(1-40-44(37,38)29-7)42-18(12(8)34)32-4-24-10-14(32)26-20(22)28-16(10)36;21-19-25-13-9(15(35)27-19)23-3-31(13)17-11(33)7-5(41-17)1-39-43(37,45)30-8-6(2-40-44(38,46)29-7)42-18(12(8)34)32-4-24-10-14(32)26-20(22)28-16(10)36;2*1-2;;;;/h9-15,18,23-24H,7-8H2,1-6H3,(H2,36,42,51)(H2,37,43,52)(H3,28,32,34,40)(H3,29,33,35,41);3-8,11-12,17-18,33-34H,1-2H2,(H2,29,37,38)(H2,30,39,46)(H3,21,25,27,35)(H3,22,26,28,36);3-8,11-12,17-18,33-34H,1-2H2,(H2,29,38,46)(H2,30,37,45)(H3,21,25,27,35)(H3,22,26,28,36);2*2H2,1H3;4*1H3/t11-,12-,13-,14+,15-,18-,23-,24-,49?,50?;5-,6-,7-,8-,11-,12-,17-,18-,45?;5-,6-,7-,8-,11-,12-,17-,18-,43?,44?;;;;;;/m111....../s1
• InChIKey: KZJRJMOZWSHSNW-HJABPZFJSA-N
• XLogP: -10.32
• TPSA: 1161.35 Ų
• H-Bond Donors: 28
• H-Bond Acceptors: 59
• Rotatable Bonds: 8
• Heavy Atoms: 153
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2388.22
LogP ≤ 5	-10.32
H-Bond Donors ≤ 5	28
H-Bond Acceptors ≤ 10	59

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'thiol_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium?

The IUPAC name of tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium (CID 157079938) is tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium.

What is the SMILES notation for tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium?

The canonical SMILES for tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium is C[C@@H]1[C@@H]2NP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]3NP(=O)([S-])OC[C@H]2O[C@H]1n1cnc2c(=O)[nH]c(N)nc21.C[NH3+].C[NH3+].Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP([O-])(=S)N[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)([O-])N[C@H]3[C@H]2O)c(=O)[nH]1.Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP([O-])(=S)N[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP([O-])(=S)N[C@H]3[C@H]2O)c(=O)[nH]1.[NH4+].[NH4+].[NH4+].[NH4+].

What is the InChIKey of tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium?

The InChIKey is KZJRJMOZWSHSNW-HJABPZFJSA-N. The full InChI is InChI=1S/C27H42N12O9P2S2Si.C20H26N12O11P2S.C20H26N12O10P2S2.2CH5N.4H3N/c1-11-14-12(46-23(11)38-9-30-16-19(38)32-25(28)34-21(16)40)7-44-50(43,52)37-15-13(8-45-49(42,51)36-14)47-24(18(15)48-53(5,6)27(2,3)4)39-10-31-17-20(39)33-26(29)35-22(17)41;21-19-25-13-9(15(35)27-19)23-3-31(13)17-11(33)7-6(43-17)2-41-45(39,46)30-8-5(1-40-44(37,38)29-7)42-18(12(8)34)32-4-24-10-14(32)26-20(22)28-16(10)36;21-19-25-13-9(15(35)27-19)23-3-31(13)17-11(33)7-5(41-17)1-39-43(37,45)30-8-6(2-40-44(38,46)29-7)42-18(12(8)34)32-4-24-10-14(32)26-20(22)28-16(10)36;2*1-2;;;;/h9-15,18,23-24H,7-8H2,1-6H3,(H2,36,42,51)(H2,37,43,52)(H3,28,32,34,40)(H3,29,33,35,41);3-8,11-12,17-18,33-34H,1-2H2,(H2,29,37,38)(H2,30,39,46)(H3,21,25,27,35)(H3,22,26,28,36);3-8,11-12,17-18,33-34H,1-2H2,(H2,29,38,46)(H2,30,37,45)(H3,21,25,27,35)(H3,22,26,28,36);2*2H2,1H3;4*1H3/t11-,12-,13-,14+,15-,18-,23-,24-,49?,50?;5-,6-,7-,8-,11-,12-,17-,18-,45?;5-,6-,7-,8-,11-,12-,17-,18-,43?,44?;;;;;;/m111....../s1.

What are the key properties of tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium?

tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium has a molecular weight of 2388.22 g/mol, XLogP of -10.32, 8 rotatable bonds, 28 hydrogen bond donors, and 59 hydrogen bond acceptors.

Where does this data come from?

All data for tetraazanium;2-amino-9-[(1R,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-18-[tert-butyl(dimethyl)silyl]oxy-9-methyl-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3,12-bis(sulfanylidene)-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;2-amino-9-[(1S,6S,8R,9R,10S,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,18-dihydroxy-3,12-dioxido-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;methylazanium is sourced from PubChem (CID 157079938), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).